·Î»ç¸£Åº(Losartan) ½ÃÀå : ÀûÀÀÁõº°, ³óµµº°, Á¦Ç° À¯Çüº°, ¿¬·ÉÃþº°, ¼ºº°, À¯Åë ä³Îº°, Çüź°, °ø±Þ¿øº°, Áö¿ªº°
Losartan Market, By indication, By Strength, By Product Type, By Age Group, By Gender, By Distribution Channel, By Form, By Source, By Geography
»óǰÄÚµå
:
1767670
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 06¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
·Î»ç¸£Åº(Losartan0 ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 16¾ï 8,000¸¸ ´Þ·¯, 2032³â¿¡´Â 22¾ï 3,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 4.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ºÐ¼® ¹üÀ§
ºÐ¼® »ó¼¼
±âÁØ ¿¬µµ
2024³â
½ÃÀå ±Ô¸ð(2025³â)
16¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â)
4.10%
¿¹Ãø ±Ý¾×(2032³â)
22¾ï 3,000¸¸ ´Þ·¯
¼¼°è ·Î»çÆ®¶õ ½ÃÀåÀº Àü ¼¼°è °íÇ÷¾Ð ¹× ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ÈûÀÔ¾î ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¾ÈÁö¿ÀÅٽŠII ¼ö¿ëü ±æÇ×Á¦ÀÎ ·Î»çÆ®¶õÀº °íÇ÷¾Ð, ½ÉºÎÀü, ´ç´¢º´¼º ½ÅÁõ Ä¡·áÁ¦·Î ³Î¸® ó¹æµÇ°í ÀÖ½À´Ï´Ù. °Ç°ÇÑ »ýȰ½À°ü°ú È¿°úÀûÀÎ Ç÷¾Ð °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ·Î»çÆ®¶õÀÇ Á¦³×¸¯ ÀǾàǰÀ» ½±°Ô ±¸ÇÒ ¼ö ÀÖ°í °¡°ÝÀÌ Àú·ÅÇØÁø °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. È¿°úÀûÀÎ Ç×°íÇ÷¾ÐÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ·Î»çÆ®¶õ ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼¼°è ·Î»çÆ®¶õ ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ¹× ±âȸ¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº °íÇ÷¾Ð°ú ½ÉºÎÀü ¹× ³úÁ¹Áß°ú °°Àº °ü·Ã ½ÉÇ÷°ü°è ÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ÁÂ½Ä »ýȰ, ºñ¸¸, ³ôÀº ½ºÆ®·¹½º ¼öÁØÀ» Ư¡À¸·Î ÇÏ´Â °Ç°¿¡ ÇØ·Î¿î »ýȰ ½À°üÀº °íÇ÷¾Ð ¹ß»ý·üÀ» Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ È¿°úÀûÀÎ Ç÷¾Ð °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àú·ÅÇÑ °¡°ÝÀÇ ·Î»çÆ®¶õ Á¦³×¸¯ ÀǾàǰÀÇ °¡¿ë¼ºÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ´ëü Ç×°íÇ÷¾ÐÁ¦ÀÇ Á¸Àç¿Í ·Î»çÆ®¶õ »ç¿ë¿¡ µû¸¥ ÀáÀçÀû ºÎÀÛ¿ë µî ½ÃÀå¿¡´Â ÀÏÁ¤ÇÑ ¾ïÁ¦¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºê·£µå ·Î»çÆ®¶õ Á¦Ç°ÀÇ Æ¯Çã ¸¸·á·Î ÀÎÇØ Á¦³×¸¯ ¾÷ü¿ÍÀÇ °æÀïÀÌ Ä¡¿ÇØÁ® ÁÖ¿ä ¾÷üµé ½ÃÀå Á¡À¯À²¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾î·Á¿ò¿¡µµ ºÒ±¸Çϰí, ½ÃÀåÀº »õ·Î¿î ¾à¹° Àü´Þ ½Ã½ºÅÛ °³¹ß, ·Î»çÆ®¶õÀÇ Ä¡·á ¿ëµµ È®´ë, °íÇ÷¾Ð À¯º´·üÀÌ ³ôÀº ½ÅÈï °æÁ¦±¹¿¡¼ÀÇ ¹Ì°³Ã´ ÀáÀç·Â µî À¯¸ÁÇÑ ¼ºÀå ±âȸ¸¦ Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾à»ç °£ Àü·«Àû Á¦ÈÞ ¹× ÇÕº´À¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È ±â¼ú Çõ½ÅÀÌ ÃËÁøµÇ°í ½ÃÀå ¹üÀ§°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º» º¸°í¼ÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ ·Î»ç¸£Åº(Rosartan) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í CAGRÀ» Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, °¢ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ, ½ÃÀå ÃËÁø ¹× ¾ïÁ¦¿äÀÎ ¹× ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ¾÷üµéÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
¼¼°è ·Î»ç¸£Åº ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÀÛ¼ºµÇ¾ú½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, Á¦ÈÞ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
"¼¼°è ·Î»ç¸£Åº ½ÃÀå" º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ·Î»ç¸£Åº ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ºÐ¼® ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ¹ßÀü
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å ¹× ½ÂÀÎ
PEST ºÐ¼®
PORTER ºÐ¼®
ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
¾÷°è µ¿Çâ
Ä¡·á ¿É¼Ç ºÐ¼®
¾àÁ¦ ³»¼º ½Ã³ª¸®¿À
»óȯ ½Ã³ª¸®¿À
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦4Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ÀûÀÀÁõº°(2020-2032³â)
°íÇ÷¾Ð
ÁÂ½É½Ç ºñ´ë(LVH)
´ç´¢º´¼º ½ÅÀåÁúȯ
±âŸ(³úÁ¹Áß µî)
Á¦5Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ³óµµº°(2020-2032³â)
Á¦6Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2032³â)
Á¦7Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ¿¬·ÉÃþº°(2020-2032³â)
Á¦8Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : ¼ºº°(2020-2032³â)
Á¦9Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : À¯Åë ä³Îº°(2020-2032³â)
º´¿ø ¾à±¹
¼Ò¸Å ¾à±¹
¿Â¶óÀÎ ¾à±¹
Á¦10Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : Çüź°(2020-2032³â)
Á¦11Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : °ø±Þ¿øº°(2020-2032³â)
Á¦12Àå ¼¼°èÀÇ ·Î»ç¸£Åº ½ÃÀå : Áö¿ªº°(2020-2032³â)
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
¸ß½ÃÄÚ
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¶ÀÏ
¿µ±¹
½ºÆäÀÎ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áß±¹
Àεµ
ÀϺ»
È£ÁÖ
Çѱ¹
ASEAN
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
秵GCC ±¹°¡
À̽º¶ó¿¤
±âŸ Áßµ¿
¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«
ºÏ¾ÆÇÁ¸®Ä«
Áß¾Ó¾ÆÇÁ¸®Ä«
Á¦13Àå °æÀï ±¸µµ
Teva Pharmaceutical Industries Ltd
Mylan N.V.
Organon LLC
Alembic Pharmaceuticals Ltd
Macleods Pharmaceuticals Ltd
Teva Pharmaceuticals Usa
Aurobindo Pharma
Lupin Limited
Reddy's Laboratories
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Torrent Pharmaceuticals Ltd
Cipla Ltd
Glenmark Pharmaceuticals
Alkem Laboratories
Granules India Ltd
Micro Labs Ltd
Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È
'Wheel of Fortune'
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Coherent Opportunity Map(COM)
Á¦15Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
Âü°í ¹®Çå
ºÐ¼® ¹æ¹ý
Coherent Market Insights¿¡ ´ëÇØ
LSH
¿µ¹® ¸ñÂ÷
Losartan Market is estimated to be valued at USD 1.68 Bn in 2025 and is expected to reach USD 2.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 1.68 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
4.10%
2032 Value Projection:
USD 2.23 Bn
The global Losartan market has witnessed significant growth in recent years, driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Losartan, an angiotensin II receptor antagonist, is widely prescribed for the treatment of high blood pressure, heart failure, and diabetic nephropathy. The market's expansion is further fueled by unhealthy lifestyles and rising awareness about the importance of effective blood pressure management. Moreover, the availability of generic Losartan products has increased their accessibility and affordability, contributing to their widespread adoption. As the demand for efficient antihypertensive medications continues to rise, the global Losartan market is poised for substantial growth in the coming years.
Market Dynamics
The global Losartan market is influenced by several key drivers, restraints, and opportunities. The primary driver for market growth is the increasing prevalence of hypertension and related cardiovascular disorders, such as heart failure and stroke. Unhealthy lifestyles characterized by sedentary behavior, obesity, and high-stress levels have led to a significant increase in the incidence of hypertension. Furthermore, the growing awareness about the importance of effective blood pressure management and the availability of affordable generic Losartan products have boosted the market's growth. However, the market also faces certain restraints, such as the presence of alternative antihypertensive medications and potential side effects associated with Losartan use. Additionally, the expiration of patents for branded Losartan products has led to increased competition from generic manufacturers, potentially impacting the market share of key players. Despite these challenges, the market presents promising opportunities for growth, including the development of novel drug delivery systems, the expansion of Losartan's therapeutic applications, and the untapped potential in emerging economies with high hypertension prevalence rates. Moreover, strategic collaborations and mergers among pharmaceutical companies are expected to drive innovation and expand market reach in the coming years.
Key features of the study
This report provides an in-depth analysis of the global Losartan market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Losartan market based on the following parameters: company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Mylan N.V., Organon LLC, Alembic Pharmaceuticals Ltd, Macleods Pharmaceuticals Ltd, Teva Pharmaceuticals Usa, Aurobindo Pharma, Lupin Limited, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd, Cipla Ltd, Glenmark Pharmaceuticals, Alkem Laboratories, Granules India Ltd, and Micro Labs Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Losartan market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Losartan market.
Market Segmentation
Indication Insights (Revenue, USD Bn, 2020 - 2032)
Hypertension
Left Ventricular Hypertrophy (LVH)
Diabetic Nephropathy
Others (Stroke, etc.)
Strength Insights (Revenue, USD Bn, 2020 - 2032)
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
Pediatric
Adult
Geriatric
Gender Insights (Revenue, USD Bn, 2020 - 2032)
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Form Insights (Revenue, USD Bn, 2020 - 2032)
Source Insights (Revenue, USD Bn, 2020 - 2032)
Contract Manufacturing Organizations
In-House Manufacturing
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U,S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Teva Pharmaceutical Industries Ltd
Mylan N.V.
Organon LLC
Alembic Pharmaceuticals Ltd
Macleods Pharmaceuticals Ltd
Teva Pharmaceuticals USA
Aurobindo Pharma
Lupin Limited
Reddy's Laboratories
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Torrent Pharmaceuticals Ltd
Cipla Ltd
Glenmark Pharmaceuticals
Alkem Laboratories
Granules India Ltd
Micro Labs Ltd
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Losartan Market, By Indication
Global Losartan Market, By Strength
Global Losartan Market, By Product Type
Global Losartan Market, By Age Group
Global Losartan Market, By Gender
Global Losartan Market, By Distribution Channel
Global Losartan Market, By Form
Global Losartan Market, By Source
Global Losartan Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
Treatment Option Analysis
Drug Resistance Scenario
Reimbursement Scenario
Regulatory Scenario
4. Global Losartan Market, By Indication, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Left Ventricular Hypertrophy (LVH)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diabetic Nephropathy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Stroke, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Losartan Market, By Strength, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
5 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
25 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
50 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
100 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Losartan Market, By Product Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Branded
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Generic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Losartan Market, By Age Group, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Losartan Market, By Gender, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Male
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Losartan Market, By Distribution Channel, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Losartan Market, By Form, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Tablet
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Powder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Suspension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Losartan Market, By Source, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Contract Manufacturing Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
In-House Manufacturing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Losartan Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Latin America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
13. Competitive Landscape
Teva Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Organon LLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alembic Pharmaceuticals Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Macleods Pharmaceuticals Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceuticals Usa
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Aurobindo Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Lupin Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Reddy's Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sun Pharmaceutical Industries Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Zydus Cadila
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Torrent Pharmaceuticals Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Cipla Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Glenmark Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alkem Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Granules India Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Micro Labs Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
14. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
15. References and Research Methodology
References
Research Methodology
About us
°ü·ÃÀÚ·á